GEMOAB MONOCLONALS GMBH NOVEL IMMUNOTHERAPEUTIC CONCEPTS

Welcome to the Brand page for “GEMOAB MONOCLONALS GMBH NOVEL IMMUNOTHERAPEUTIC CONCEPTS”, which is offered here for The mark consists of the word gemoab located above the words monoclonals gmbh both of which are located above the words novel immunotherapeutic concepts all of which are in stylized fonts along with an abstract illustration of a circle and lines in a general y shape that is located to the left of the word gemoab.;color is not claimed as a feature of the mark.;business management and organization consultancy; business consulting services; advisory services for business management; consultancy relating to business organisation; personnel management consultancy; business investigation; logistics management in the field of medicine;the wording gemoab has no meaning in a foreign language.;blood bank services;monoclonals gmbh novel immunotherapeutic concepts;technical advice and consultancy in the field of biotechnology, medical technology and information technology; scientific consultancy in the field of biotechnology; scientific consultancy in the field of medical technology; scientific consultancy in the field of information technology; chemical research, for others; biotechnology research, for others; medical technology research, for others;.

Its status is currently believed to be active. Its class is unavailable. “GEMOAB MONOCLONALS GMBH NOVEL IMMUNOTHERAPEUTIC CONCEPTS” is believed to be currently owned by “Cellex Gesellschaft für Zellgewinnung mbH”.